Services
Partnership Opportunities for Industry
STML offers collaborative opportunities for:
Pharmaceutical companies developing metabolic and diabetes therapies.
Biotechnology companies developing innovative biologics, small molecules, gene therapies, or regenerative medicine approaches.
Emerging European biotech companies seeking specialized preclinical expertise.
Partnership models include:
Confidential research collaborations.
Fee-for-service experimental studies.
Joint grant applications.
Translational research partnerships.
Access to specialized metabolic platforms and scientific expertise.
By combining world-leading expertise in metabolism, diabetes, stem cell biology, and in vivo physiology, STML provides industry partners with a unique academic-industry interface to accelerate therapeutic discovery and preclinical development.
Preclinical Metabolic Disease and Translational In Vivo Studies
The Signal Transduction and Metabolism Laboratory (STML) provides industry partners with specialized preclinical capabilities to evaluate therapeutic candidates in validated models of diabetes, obesity, insulin resistance, metabolic liver disease, and related inflammatory disorders. Our team combines rigorous in vivo methodology with deep disease expertise to generate data that de-risks the transition from bench to clinic.
In vivo metabolic efficacy studies
Quantitative assessment of insulin action and glucose metabolism
Preclinical disease models and therapeutic validation
Advanced surgical and transplantation expertise
Molecular Metabolism and Advanced Cell-Based Model Services
The Signal Transduction and Metabolism Laboratory (STML) at the Université libre de Bruxelles (ULB) provides specialized research services and collaborative platforms for pharmaceutical and biotechnology companies developing innovative therapies in metabolic diseases, diabetes, obesity, liver disorders, inflammation, and regenerative medicine. Leveraging human stem cell models and genome engineering, we help partners validate targets and mechanisms with translational relevance from the earliest stages of discovery.
Human stem cell-derived metabolic models
Genome engineering and target validation platforms
Functional metabolic profiling
Molecular signaling and biomarker analysis
Support our research
You have the opportunity to become a supporter of the work being undertaken at the Signal Transduction & Metabolism Laboratory - your support will help the new generation of junior researchers become experienced scientists and may make a difference in the search of better treatments for diabetes and liver cancer.
